Zhenhua Hu1, Zhiwei Li, Jie Xiang, Jie Zhou, Sheng Yan, Jian Wu, Lin Zhou, Shusen Zheng. 1. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Key Laboratory of Combined Multi-organ Transplantation Ministry of Public Health Key Laboratory of Organ Transplantation, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China, huzhenh@zju.edu.cn.
Abstract
BACKGROUND/AIM: Liver transplantation is a well-recognized treatment for non-resectable hepatocellular carcinoma (HCC); however, the overall survival and waiting list removal rates for hepatitis C virus (HCV)-related HCC have not been assessed. METHODS: The present study included 11,146 patients with HCC and 64,788 patients without HCC, listed for liver transplantation on the Scientific Registry of Transplant Recipients database between 2003 and 2010. RESULTS: In a multivariate analysis, HCV infection was an independent predictor of being transplanted or remaining on the waiting list in HCC candidates (HR 0.65, 95% CI 0.60-0.71, p < 0.001). However, patients in the advanced status (model for end-stage liver disease score over 20, tumor stage exceed tumor-node-metastasis stage II, or alpha fetoprotein lover 400 ng/ml) but without HCV had better post-transplant survival than patients in the advanced status and with HCV (64 vs. 47% at 5 years, p < 0.001), and comparable survival to patients with HCV but not in the advanced status (62%, p = 0.461). CONCLUSIONS: HCC candidates with HCV infection are more likely to be transplanted, remain on the waiting list for longer, and have worse post-transplant survival. Patients in the advanced status but without HCV also could share a similar post-transplant survival to those not in the advanced status but with HCV.
BACKGROUND/AIM: Liver transplantation is a well-recognized treatment for non-resectable hepatocellular carcinoma (HCC); however, the overall survival and waiting list removal rates for hepatitis C virus (HCV)-related HCC have not been assessed. METHODS: The present study included 11,146 patients with HCC and 64,788 patients without HCC, listed for liver transplantation on the Scientific Registry of Transplant Recipients database between 2003 and 2010. RESULTS: In a multivariate analysis, HCV infection was an independent predictor of being transplanted or remaining on the waiting list in HCC candidates (HR 0.65, 95% CI 0.60-0.71, p < 0.001). However, patients in the advanced status (model for end-stage liver disease score over 20, tumor stage exceed tumor-node-metastasis stage II, or alpha fetoprotein lover 400 ng/ml) but without HCV had better post-transplant survival than patients in the advanced status and with HCV (64 vs. 47% at 5 years, p < 0.001), and comparable survival to patients with HCV but not in the advanced status (62%, p = 0.461). CONCLUSIONS: HCC candidates with HCV infection are more likely to be transplanted, remain on the waiting list for longer, and have worse post-transplant survival. Patients in the advanced status but without HCV also could share a similar post-transplant survival to those not in the advanced status but with HCV.
Authors: Philipp Dutkowski; Christian E Oberkofler; Markus Béchir; Beat Müllhaupt; Andreas Geier; Dimitri A Raptis; Pierre-Alain Clavien Journal: Liver Transpl Date: 2011-06 Impact factor: 5.799
Authors: Espen Melum; Styrbjörn Friman; Kristian Bjøro; Allan Rasmussen; Helena Isoniemi; Henrik Gjertsen; Lars Bäckman; Antti Oksanen; Michael Olausson; Frans F Duraj; Bo-Göran Ericzon Journal: J Hepatol Date: 2007-07-23 Impact factor: 25.083
Authors: John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil Journal: Ann Surg Date: 2007-09 Impact factor: 12.969
Authors: Vincenzo Mazzaferro; Yun Shin Chun; Ronnie T P Poon; Myron E Schwartz; Francis Y Yao; J Wallis Marsh; Sherrie Bhoori; Sung-Gyu Lee Journal: Ann Surg Oncol Date: 2008-01-31 Impact factor: 5.344
Authors: Marcio F Chedid; Leandro A Scaffaro; Aljamir D Chedid; Antonio C Maciel; Carlos Thadeu S Cerski; Matheus J Reis; Tomaz J M Grezzana-Filho; Alexandre de Araujo; Ian Leipnitz; Cleber D P Kruel; Mario R Alvares-da-Silva; Cleber R P Kruel Journal: Gastroenterol Res Pract Date: 2015-12-27 Impact factor: 2.260